IBL Tool - Digitale Bibliotheek

Digitale Bibliotheek

Sluiten

Tijdschrift beschrijving

Alle jaargangen van het bijbehorende tijdschrift

Alle afleveringen van het bijbehorende jaargang

Alle artikelen van de bijbehorende aflevering

70 gevonden resultaten

nr	titel	auteur	tijdschrift	jaar	jaarg.	afl.	pagina('s)	type
1	Acarbose in diabetes gives value for money			2006	1555	1	p. 5	artikel
2	Adjunctive inhaled insulin as sweet as glibenclamide in T2DM			2006	1555	1	p. 13	artikel
3	Adjuvanted, whole-virion avian influenza vaccine takes wing			2006	1555	1	p. 5	artikel
4	Alendronic acid approved for osteoporosis in Japan			2006	1555	1	p. 23	artikel
5	Alglucosidase-alfa for infantile-onset Pompe disease			2006	1555	1	p. 11	artikel
6	Alvimopan: irregular results in opioid-induced bowel dysfunction			2006	1555	1	p. 6	artikel
7	Anastrozole better tolerated than tamoxifen in the long run			2006	1555	1	p. 21	artikel
8	Antibody therapy phase I trial safety remains topical			2006	1555	1	p. 2	artikel
9	β-blockers may be beneficial for long QT syndrome			2006	1555	1	p. 14	artikel
10	Budesonide/formoterol vs salbutamol, salmeterol/fluticasone propionate for onset of action in COPD			2006	1555	1	p. 12	artikel
11	Chemotherapy before surgery in advanced epithelial ovarian cancer			2006	1555	1	p. 12	artikel
12	Chromium beneficial in treating type 2 diabetes			2006	1555	1	p. 9	artikel
13	Docetaxel + carboplatin has the edge for advanced NSCLC			2006	1555	1	p. 13	artikel
14	Dosage and duration of statins affects coronary collateral development in advanced CAD			2006	1555	1	p. 11	artikel
15	Early ciclosporin withdrawal good value in renal transplant			2006	1555	1	p. 3	artikel
16	Enoxaparin bleeding rates similar to/lower than heparin in PCI			2006	1555	1	p. 20	artikel
17	ERCC1-negative NSCLC tumours positive for cisplatin chemo			2006	1555	1	p. 11	artikel
18	EU product approvals			2006	1555	1	p. 23	artikel
19	Everolimus- vs paclitaxel-eluting coronary stents			2006	1555	1	p. 13	artikel
20	Expression of HLA class I improves survival in BCG-treated patients with bladder cancer			2006	1555	1	p. 14	artikel
21	Fingolimod decreases heart rate, increases PR and RR intervals			2006	1555	1	p. 19	artikel
22	FOLFOX4 superior to rIFL for metastatic colorectal cancer			2006	1555	1	p. 17	artikel
23	Folic acid reduces levels of inflammatory mediators in overweight subjects			2006	1555	1	p. 18	artikel
24	Fosamprenavir has no fear in taking on the favourite			2006	1555	1	p. 15-16	artikel
25	Green tea reduces risks of all-cause death and CVD death			2006	1555	1	p. 12	artikel
26	Higher costs with nonbranded ciclosporin than with branded ciclosporin			2006	1555	1	p. 5	artikel
27	If something sounds too good to be true . . .			2006	1555	1	p. 3	artikel
28	Imatinib beneficial for PAH: 2 case reports			2006	1555	1	p. 6	artikel
29	Insulin pump beneficial for kids with type 1 DM			2006	1555	1	p. 17	artikel
30	Less cognitive effects with lamotrigine than topiramate			2006	1555	1	p. 22	artikel
31	Loperamide/simethicone generic approved in the US			2006	1555	1	p. 23	artikel
32	LVH is associated with new-onset AF in hypertensive patients			2006	1555	1	p. 14	artikel
33	Meloxicam delays ovulation in healthy women			2006	1555	1	p. 19	artikel
34	Metformin may improve myocardial ischaemia			2006	1555	1	p. 12	artikel
35	Metformin may prevent early puberty			2006	1555	1	p. 14	artikel
36	Moderators of treatment outcomes must be remembered			2006	1555	1	p. 3	artikel
37	Montelukast decreases exhaled leukotriene E4 in children with asthma			2006	1555	1	p. 19	artikel
38	NAPc2 may reduce ischaemia in patients with NSTE-ACS			2006	1555	1	p. 6	artikel
39	NSAIDs: increased COX-2 selectivity may increase CV risk			2006	1555	1	p. 20	artikel
40	Oblimersen not recommended for CML by FDA committee			2006	1555	1	p. 23	artikel
41	Omega-3 ethylester concentrate a worthy addition for MI prevention			2006	1555	1	p. 4	artikel
42	Once weekly LB 03002 comparable to daily somatropin			2006	1555	1	p. 19	artikel
43	Orlistat may be beneficial for glycaemic control			2006	1555	1	p. 11	artikel
44	Other EU regulatory news			2006	1555	1	p. 22	artikel
45	Paclitaxel/fluorouracil/hydroxycarbamide plus radiotherapy for advanced nasopharyngeal carcinoma			2006	1555	1	p. 12	artikel
46	Pemetrexed effective against metastatic urothelial cancer			2006	1555	1	p. 14	artikel
47	Peppermint oil soothes gastrointestinal spasms during DCBM			2006	1555	1	p. 9	artikel
48	Perioperative nesiritide improves outcomes after coronary bypass			2006	1555	1	p. 11	artikel
49	Pravastatin provides promising proliferation of adiponectin			2006	1555	1	p. 18	artikel
50	Pre-treatment changes in brain function associated with clinical outcome in depression			2006	1555	1	p. 9	artikel
51	Product approvals in India			2006	1555	1	p. 22	artikel
52	Recombinant human thrombin vs bovine thrombin as surgical haemostat			2006	1555	1	p. 13	artikel
53	Risperidone monotherapy may be effective for post-traumatic stress disorder			2006	1555	1	p. 9	artikel
54	Risperidone vs zuclopenthixol in schizophrenia plus SUD			2006	1555	1	p. 17	artikel
55	Rofecoxib: increased risk of renal and cardiovascular effects			2006	1555	1	p. 21	artikel
56	R 744 reaches milestone in anaemia management			2006	1555	1	p. 7-8	artikel
57	Superiority of virgin olive oil against CV risk factors			2006	1555	1	p. 18	artikel
58	Superior 2-year REALITY-trial results for sirolimus-eluting stent			2006	1555	1	p. 14	artikel
59	Tiotropium bromide effective for mild COPD			2006	1555	1	p. 13	artikel
60	TMPT genotyping before mercaptopurine cost effective			2006	1555	1	p. 4	artikel
61	Topiramate may be beneficial for trichotillomania			2006	1555	1	p. 17	artikel
62	Trimetazidine beneficial in treating heart failure			2006	1555	1	p. 8	artikel
63	Up the loading dose, up the effects with clopidogrel			2006	1555	1	p. 18	artikel
64	US FDA warns about ibuprofen and aspirin interaction			2006	1555	1	p. 19	artikel
65	US product launches			2006	1555	1	p. 22	artikel
66	Valsartan has greater VALUE than amlodipine for hypertension			2006	1555	1	p. 8	artikel
67	VAS 991 immune modulation effective in some HF patients			2006	1555	1	p. 6	artikel
68	Wait-and-see a winning approach for AOM in more ways than one			2006	1555	1	p. 1	artikel
69	72-week treatment more effective than 48-week in hepatitis C			2006	1555	1	p. 9	artikel
70	Xenon vs propofol for supplementary general anaesthesia			2006	1555	1	p. 12	artikel

70 gevonden resultaten

Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland